OOG- Eye Research Association

Stop blindness in children!

OOG / EYE Research Association has set its goal on helping to finance cutting-edge research to find treatments for blindness in children due to genetic eye diseases. The association also aims to inform people affected by these eye disease about the progress that is being made in (inter)national eye research.

“There are hopeful developments in the research field of gene - and stem cell therapy to combat blinding genetic eye diseases. This is an exciting time to develop pioneering new treatments to cure blindness in children. where a high financial impulse for scientific research is necessary” – according to Prof. Dr. Camiel Boon, MD, Professor in Genetic Eye Diseases

We aim for:

Raising research funds on a structural basis, to support cutting-edge research
An association with an active membership involvement
Passion and versatility to achieve the best research

The entire proceeds of the donations go towards scientific research!

Click here for your donation

News

Actueel

Donation from OOG (Eye Research Society) to REPEAT study at Amsterdam UMC

The board of the Amsterdam UMC Foundation, on the advice of the Advisory Council of OOG, has awarded a donation of € 315,562 to the REPEAT study, a groundbreaking research project on the impact of retinitis pigmentosa (RP) and the effectiveness of gene therapy. This research, led by Prof. Dr. Camiel Boon, aims to test and improve the reliability of various eye examinations in patients with RP. read more

Webinar: hereditary eye diseases

On April 15, 2024, a free knowledge-sharing webinar was hosted by Prof. dr. Camiel Boon (Professor Ophthamology at Amsterdam UMC ), Prof. dr. Arthur Bergen (professor in the Human Genetics of Eye Diseases at Amsterdam UMC) and dr. Jessica Karuntu (researcher at LUMC). read more

Free webinar to share knowledge on April 15, 2024 at 08:00 (20:00) PM Amsterdam time

On April 15, 2024 at 08:00 (20:00) PM Amsterdam time Prof. Dr. Camiel Boon (Eye Specialist and Professor Ophthamology at Amsterdam UMC) and Prof. Dr. Arthur Bergen (Professor in the Human Genetics of Eye Diseases at Amsterdam UMC) will give a free webinar to share knowledge about hereditary eye disease like Retinitis Pigmentosa (RP) and Macular Degeneration and the development of new treatments. read more

A interview with Prof. Dr. Camiel Boon, Professor in Ophthalmology

In the radio programme “The Night of” on Dutch national radio, on 12th October 2023, Prof. Dr. Camiel Boon was the special guest. read more

Establishment of OOG, the Eye Research Association

On the 11th September 2023, the Oog Onderzoek Genootschap – OOG / EYE Research Association was established in collaboration with the Amsterdam UMC Foundation. This specific fund will help finance research into innovative treatments such as gene therapy for rare eye diseases, with the specific goal: to prevent blindness in children. By initiating this fund, the initiators want to speed up this pioneering research. read more

Get involved and help

Together we can make a difference!

OOG is an organization run by dedicated volunteers, with no financial reward for those involved. Neither the advisory board, nor the “4Light” organizers receive any financial compensation. The entire proceeds of the donations are spent on scientific research into blinding genetic eye diseases, with the focus on those in children.

Click here to join us

Initiatives for eye research funding

Some successful initiatives

Prof. Dr. Camiel Boon

Eye Specialist and Professor Ophthamology at Amsterdam UMC

‘The Eye is such a beautiful and wonderous small organ. An instrument with a super speciality with which we can view our surroundings with all the details of its beauty and complexity. Unfortunately many things can go wrong with our eyes. Such a super specialized organ requires a very specialized approach. As an Eye Specialist, my focus is mainly on diseases/disorders of the retina, hereditary eye disease and micro surgery operations of the retina.
The daily contact with patients confronted with threatening eye disease, motivates me in my scientific research into innovative therapy. There are still too many eye diseases we cannot treat effectively. Together with my team we are trying to change that.’